Kedrion Biopharma Is An International Company Based In Tuscanyitalyspecializing In The Collection And Fractionation Of Blood Plasma To Create Plasma Derived Therapeutic Productsfounded In 2001 By The Marcucci Familykedrion Has Its Origins In A Small Pharmaceutical Laboratory Established In The 1950Sthe Company Operates A Network Of Plasma Collection Centersprimarily In The United States And Europeand Plays A Vital Role In Producing Life Saving Treatments For Patients With Severe Medical Conditions Kedrion Produces A Variety Of Plasma Derived Therapiesincluding Treatments For Hemophilia And Immune Deficienciesone Of Its Key Products Is Ryplazimthe First And Only Treatment For Plasminogen Deficiency Type 1Which Has Received Fda Approval For Production At Its Facility In Bolognanathe Company Distributes Its Products Globallyreaching Patients In Over 100 Countriesand Continues To Expand Its Operations And Product Offeringsdemonstrating Strong Growth And A Commitment To Serving Healthcare Providers And Patients In Need
